A share price of Strata Critical Medical Inc [SRTA] is currently trading at $5.65, down -1.57%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SRTA shares have gain 4.63% over the last week, with a monthly amount glided 8.45%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Lake Street started tracking the stock with Buy rating on February 26, 2025, and set its price target to $6.50. On July 18, 2023, Ladenburg Thalmann initiated with a Buy rating and assigned a price target of $13 on the stock. Ladenburg Thalmann started tracking the stock assigning a Buy rating and suggested a price target of $13 on July 17, 2023. Oppenheimer initiated its recommendation with a Outperform and recommended $14 as its price target on September 28, 2021. JP Morgan started tracking with a Overweight rating for this stock on September 09, 2021, and assigned it a price target of $16. In a note dated September 01, 2021, Deutsche Bank initiated an Buy rating and provided a target price of $15 on this stock.
Strata Critical Medical Inc experienced fluctuations in its stock price throughout the past year between $2.35 and $6.02. Currently, Wall Street analysts expect the stock to reach $7.25 within the next 12 months. Strata Critical Medical Inc [NASDAQ: SRTA] shares were valued at $5.65 at the most recent close of the market. An investor can expect a potential return of 28.32% based on the average SRTA price forecast.
Analyzing the SRTA fundamentals
Trailing Twelve Months sales for Strata Critical Medical Inc [NASDAQ:SRTA] were 228.76M which represents -34.16% decline. Gross Profit Margin for this corporation currently stands at 0.24% with Operating Profit Margin at -0.12%, Pretax Profit Margin comes in at -0.12%, and Net Profit Margin reading is 0.18%. To continue investigating profitability, this company’s Return on Assets is posted at 0.12, Equity is 0.17 and Total Capital is -0.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Strata Critical Medical Inc [NASDAQ:SRTA] is 4.39. In addition, the Quick Ratio stands at 4.39 and the Cash Ratio stands at 0.82. Considering the valuation of this stock, the price to sales ratio is 2.13, the price to book ratio is 1.72.
Transactions by insiders
Recent insider trading involved Heyburn William A., Co-CEO and CFO, that happened on Dec 09 ’25 when 17000.0 shares were purchased. Director, LAUCK ANDREW completed a deal on Dec 05 ’25 to buy 5000.0 shares. Meanwhile, Director Love Reginald sold 11000.0 shares on Nov 20 ’25.
